Basel Medical Group Ltd Registered Direct Offering

Basel Medical Group Ltd, a British Virgin Islands business company, has entered into a placement agency agreement with Cathay Securities, Inc. for a registered direct offering. The company will issue and sell 6,000,000 units at a price of US$1.33 per unit. Each unit consists of one ordinary share or one pre-funded warrant and one common warrant to purchase an ordinary share. The offering is expected to raise approximately US$7.98 million in gross proceeds, with net proceeds estimated at US$7.28 million. These funds will be used for general working capital, mergers and acquisitions, and other corporate purposes. The ordinary shares are listed on the Nasdaq Capital Market under the symbol "BMGL". Common warrants are exercisable immediately and expire five years from issuance, with an option for zero cash exercise, potentially resulting in the issuance of an additional 6,000,000 ordinary shares without further cash to the company. Pre-funded warrants are offered in lieu of ordinary shares to purchasers whose beneficial ownership might exceed 4.99% (or 9.99% at their election), with a nominal exercise price of US$0.01. The offering is subject to customary closing conditions, including the accuracy of representations and warranties, and satisfactory legal and auditor opinions. Lock-up agreements are in place for the company, its officers, directors, and major shareholders, restricting disposal of shares for 180 days post-offering.